Retraction notices

ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)

Type
Retraction
Notice date
3/15/2021 0:00
Journal
Annals of Oncology
Publisher
Elsevier
Notice DOI
10.1016/j.annonc.2021.01.009
Original paper DOI
10.1016/j.annonc.2020.10.517

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.